Succinylation Links Metabolic Reductions to Amyloid and Tau Pathology
暂无分享,去创建一个
Elizabeth T. Anderson | V. Haroutunian | M. Beal | W. Klein | S. Gandy | D. Eliezer | B. Sagdullaev | K. Viola | G. Gibson | Victor Tapias | Hening Lin | E. Ivanova | Diana Acosta | Hui Xu | R. Bhawal | Huanlian Chen | S. Zhang | Yun Yang | Ruchika Bhawal | Hening Lin
[1] G. Gibson,et al. Succinylation Links Metabolism to Protein Functions , 2019, Neurochemical Research.
[2] M. Coletta,et al. Ubiquitin binds the amyloid β peptide and interferes with its clearance pathways† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c8sc03394c , 2019, Chemical science.
[3] E. Nogales,et al. Near-atomic model of microtubule-tau interactions , 2018, Science.
[4] W. Klein,et al. The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade , 2018, Journal of Alzheimer's disease : JAD.
[5] Andrew J. Saykin,et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer disease: a longitudinal study , 2018, The Lancet Neurology.
[6] Jie He,et al. KAT2A coupled with the α-KGDH complex acts as a histone H3 succinyltransferase , 2017, Nature.
[7] L. Petrucelli,et al. An acetylation–phosphorylation switch that regulates tau aggregation propensity and function , 2017, The Journal of Biological Chemistry.
[8] A. Murzin,et al. Cryo-EM structures of Tau filaments from Alzheimer’s disease brain , 2017, Nature.
[9] G. Gibson,et al. Mild metabolic perturbations alter succinylation of mitochondrial proteins , 2017, Journal of neuroscience research.
[10] A. Tripathy,et al. A Dual Pathogenic Mechanism Links Tau Acetylation to Sporadic Tauopathy , 2017, Scientific Reports.
[11] G. Gibson,et al. Mild mitochondrial metabolic deficits by α-ketoglutarate dehydrogenase inhibition cause prominent changes in intracellular autophagic signaling: Potential role in the pathobiology of Alzheimer's disease , 2016, Neurochemistry International.
[12] Weibo Jin,et al. Proteome-Wide Identification of Lysine Succinylation in the Proteins of Tomato (Solanum lycopersicum) , 2016, PloS one.
[13] Jianyi Pan,et al. Global Analysis of Protein Lysine Succinylation Profiles and Their Overlap with Lysine Acetylation in the Marine Bacterium Vibrio parahemolyticus. , 2015, Journal of proteome research.
[14] S. Zhang,et al. Alpha‐ketoglutarate dehydrogenase complex‐dependent succinylation of proteins in neurons and neuronal cell lines , 2015, Journal of neurochemistry.
[15] Henning Urlaub,et al. Tau stabilizes microtubules by binding at the interface between tubulin heterodimers , 2015, Proceedings of the National Academy of Sciences.
[16] I. Landrieu,et al. Mechanism of Tau-promoted microtubule assembly as probed by NMR spectroscopy. , 2014, Journal of the American Chemical Society.
[17] E. Michelakis,et al. A Nuclear Pyruvate Dehydrogenase Complex Is Important for the Generation of Acetyl-CoA and Histone Acetylation , 2014, Cell.
[18] N. Krogan,et al. Critical Role of Acetylation in Tau-Mediated Neurodegeneration and Cognitive Deficits , 2015, Nature Medicine.
[19] Han-Chang Huang,et al. Relationship between amyloid-beta and the ubiquitin–proteasome system in Alzheimer’s disease , 2014, Neurological research.
[20] Matthew J. Rardin,et al. SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. , 2013, Cell metabolism.
[21] Hening Lin,et al. Identification of Lysine Succinylation Substrates and the Succinylation Regulatory Enzyme CobB in Escherichia coli* , 2013, Molecular & Cellular Proteomics.
[22] R. Tanzi,et al. ADAM10 Missense Mutations Potentiate β-Amyloid Accumulation by Impairing Prodomain Chaperone Function , 2013, Neuron.
[23] Sebastian A. Wagner,et al. Lysine succinylation is a frequently occurring modification in prokaryotes and eukaryotes and extensively overlaps with acetylation. , 2013, Cell reports.
[24] A. Mauleon,et al. ATP5H/KCTD2 locus is associated with Alzheimer's disease risk , 2013, Molecular Psychiatry.
[25] Yingming Zhao,et al. SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. , 2013, Molecular cell.
[26] U. Sengupta,et al. Identification of oligomers at early stages of tau aggregation in Alzheimer's disease , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] Benjamin R. Rost,et al. Novel APP/Aβ mutation K16N produces highly toxic heteromeric Aβ oligomers , 2012, EMBO molecular medicine.
[28] G. Bitan,et al. A key role for lysine residues in amyloid β-protein folding, assembly, and toxicity. , 2012, ACS chemical neuroscience.
[29] Johan Auwerx,et al. Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase , 2011, Science.
[30] Ran Friedman,et al. Aggregation of amyloids in a cellular context: modelling and experiment. , 2011, The Biochemical journal.
[31] Daniel Schwartz,et al. Biological sequence motif discovery using motif-x. , 2011, Current protocols in bioinformatics.
[32] J. Trojanowski,et al. The acetylation of tau inhibits its function and promotes pathological tau aggregation. , 2011, Nature communications.
[33] V. Haroutunian,et al. Acetylation of Tau Inhibits Its Degradation and Contributes to Tauopathy , 2010, Neuron.
[34] Isidro Ferrer,et al. Mitochondrial ATP‐Synthase in the Entorhinal Cortex Is a Target of Oxidative Stress at Stages I/II of Alzheimer's Disease Pathology , 2010, Brain pathology.
[35] J. Kelly,et al. Site-specific modification of Alzheimer's peptides by cholesterol oxidation products enhances aggregation energetics and neurotoxicity , 2009, Proceedings of the National Academy of Sciences.
[36] K. Gevaert,et al. Improved visualization of protein consensus sequences by iceLogo , 2009, Nature Methods.
[37] M. Beal,et al. Mitochondrial dihydrolipoyl succinyltransferase deficiency accelerates amyloid pathology and memory deficit in a transgenic mouse model of amyloid deposition. , 2009, Free radical biology & medicine.
[38] E. Bigio,et al. Monoclonal antibodies that target pathological assemblies of Aβ , 2007, Journal of neurochemistry.
[39] V. Lee,et al. Characterization of two VQIXXK motifs for tau fibrillization in vitro. , 2006, Biochemistry.
[40] E. Mandelkow,et al. The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis. , 2006, Biochemistry.
[41] D. Kirschner,et al. The Formation of Straight and Twisted Filaments from Short Tau Peptides* , 2004, Journal of Biological Chemistry.
[42] E. Mandelkow,et al. Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on beta-structure in the core domain. , 2004, Biochemistry.
[43] E. Mandelkow,et al. Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[44] P. Davies,et al. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein , 1999, Nature.
[45] L. Tjernberg,et al. Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand (*) , 1996, The Journal of Biological Chemistry.
[46] S. Kish,et al. Brain α‐Ketoglutarate Dehydrotenase Complex Activity in Alzheimer's Disease , 1993 .
[47] M. Mattson,et al. Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: Prevention by NGF and bFGF , 1992, Experimental Neurology.
[48] R. Black,et al. Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation. , 1990, Archives of Neurology.
[49] Maja O’Connor,et al. A Longitudinal Study , 2013 .
[50] Aileen B. Sedman,et al. A longitudinal study , 1987 .